WARD Surgery RCT II

WARD Surgical Randomized Clinical Trial II (RCT)

Study design
Randomized Clinical Trial
Sample size
504 participants
Study sites

Copenhagen University hospitals; Rigshospitalet, Bispebjerg and Hvidovre

Inclusion criteria

Cancer surgery in general anesthesia, with an expected surgical duration of more than 2 hours, and at least 2 overnight stays in the hospital after surgery

Study procedures

Continuous wireless recording of vital values with patients randomized to either no monitoring, or nurse based monitoring of a mobile phone app with vital signs displayed and alerts for sustained deviations.

Outcome

Adverse events and serious adverse events. Days alive and out of hospital.

NCT
NCT06269198